Oasmia Pharmaceutical Ab Stock Market Value
| OASMY Stock | USD 0.01 0.00 0.00% |
| Symbol | Oasmia |
Oasmia Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oasmia Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oasmia Pharmaceutical.
| 12/02/2025 |
| 01/01/2026 |
If you would invest 0.00 in Oasmia Pharmaceutical on December 2, 2025 and sell it all today you would earn a total of 0.00 from holding Oasmia Pharmaceutical AB or generate 0.0% return on investment in Oasmia Pharmaceutical over 30 days. Oasmia Pharmaceutical is related to or competes with BioQuest Corp, Eco-Growth Strategies, Medicure, Luff Enterprises, Mydecine Innovations, OpGen, and Eagle Pharmaceuticals. Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology primarily in Swede... More
Oasmia Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oasmia Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oasmia Pharmaceutical AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 150.0 |
Oasmia Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oasmia Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oasmia Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Oasmia Pharmaceutical historical prices to predict the future Oasmia Pharmaceutical's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.88) | |||
| Total Risk Alpha | (1.90) | |||
| Treynor Ratio | (0.34) |
Oasmia Pharmaceutical Backtested Returns
Oasmia Pharmaceutical maintains Sharpe Ratio (i.e., Efficiency) of -0.0473, which implies the firm had a -0.0473 % return per unit of risk over the last 3 months. Oasmia Pharmaceutical exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oasmia Pharmaceutical's Risk Adjusted Performance of (0.02), coefficient of variation of (2,164), and Variance of 268.65 to confirm the risk estimate we provide. The company holds a Beta of 2.23, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Oasmia Pharmaceutical will likely underperform. At this point, Oasmia Pharmaceutical has a negative expected return of -0.79%. Please make sure to check Oasmia Pharmaceutical's risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and day median price , to decide if Oasmia Pharmaceutical performance from the past will be repeated at some point in the near future.
Auto-correlation | 1.00 |
Perfect predictability
Oasmia Pharmaceutical AB has perfect predictability. Overlapping area represents the amount of predictability between Oasmia Pharmaceutical time series from 2nd of December 2025 to 17th of December 2025 and 17th of December 2025 to 1st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oasmia Pharmaceutical price movement. The serial correlation of 1.0 indicates that 100.0% of current Oasmia Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Oasmia Pharmaceutical lagged returns against current returns
Autocorrelation, which is Oasmia Pharmaceutical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oasmia Pharmaceutical's pink sheet expected returns. We can calculate the autocorrelation of Oasmia Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Oasmia Pharmaceutical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Oasmia Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oasmia Pharmaceutical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oasmia Pharmaceutical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oasmia Pharmaceutical pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Oasmia Pharmaceutical Lagged Returns
When evaluating Oasmia Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oasmia Pharmaceutical pink sheet have on its future price. Oasmia Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oasmia Pharmaceutical autocorrelation shows the relationship between Oasmia Pharmaceutical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Oasmia Pharmaceutical AB.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Oasmia Pink Sheet Analysis
When running Oasmia Pharmaceutical's price analysis, check to measure Oasmia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oasmia Pharmaceutical is operating at the current time. Most of Oasmia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Oasmia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oasmia Pharmaceutical's price. Additionally, you may evaluate how the addition of Oasmia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.